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In Brief
Hangen et al. show that the mitochondrial
protein AIF regulates the biogenesis of
respiratory chain complexes by
interacting with, and by controlling the
mitochondrial import of the mammalian
homolog of yeast MIA40, CHCHD4, which
is the central component of a redox-
sensitive mitochondrial intermembrane
space import machinery.
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Apoptosis-inducing factor (AIF) is a mitochondrial
flavoprotein that, beyond its apoptotic function, is
required for the normal expression of major respira-
tory chain complexes. Here we identified an AIF-
interacting protein, CHCHD4, which is the central
component of a redox-sensitive mitochondrial inter-
membrane space import machinery. Depletion or
hypomorphic mutation of AIF caused a downregula-
tion of CHCHD4 protein by diminishing its mitochon-
drial import. CHCHD4 depletion sufficed to induce a
respiratory defect that mimicked that observed in
AIF-deficient cells. CHCHD4 levels could be restored
in AIF-deficient cells by enforcing its AIF-inde-
pendent mitochondrial localization. This modified
CHCHD4 protein reestablished respiratory function
in AIF-deficient cells and enabled AIF-deficientMoleembryoid bodies to undergo cavitation, a process
of programmed cell death required for embryonic
morphogenesis. These findings explain how AIF
contributes to the biogenesis of respiratory chain
complexes, and they establish an unexpected link
between the vital function of AIF and the propensity
of cells to undergo apoptosis.
INTRODUCTION
Apoptosis-inducing factor (AIF) was initially characterized as a
membrane-bound redox-active flavoprotein that is confined to
the mitochondrial intermembrane space (IMS) of healthy cells,
yet translocates to the nucleus upon the apoptosis-associated
induction of mitochondrial outer membrane permeabilization
(MOMP) (Susin et al., 1999) coupled to its proteolysis by
calpains (Norberg et al., 2010). AIF has been involved in the
execution of apoptosis throughout eukaryote phylogeny, incular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Inc. 1001
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Figure 1. Physical Interaction between AIF
and CHCHD4
(A) Identification of CHCHD4/MIA40 as an AIF-
binding protein by immunoprecipitation of AIF
(or as a control an isotype-matched rabbit IgG).
Mass spectrometry-identified peptides that match
CHCHD4 are underlined.
(B) Co-immunoprecipitation of AIF and CHCHD4
as performed on human cancer cell lysates. The
presence of the indicated protein in the immune
complex was checked by immunoblot. Whole-cell
extract represents 25% of the input.
(C–E) Interaction of recombinant CHCHD4 with
AIF. (C) Interaction of GST-tagged cysteine point
mutants of CHCHD4 with recombinant AIF (rAIF) is
shown. (D and E) Interactions of GST-tagged full-
length and truncation mutants of CHCHD4 either
with AIF contained in the U2OS cells lysate (D) or
with rAIF (E) are shown. The indicated CHCHD4
derivatives (schematic presentations at bottom)
were immobilized on beads and then evaluated for
their capacity to bind AIF. Experiments were per-
formed at least three times, yielding similar results.
See also Figure S1.yeast, filamentous fungi, nematodes, flies, and mammals
(Hangen et al., 2010a; Joza et al., 2001). In the cytosol, AIF can
signal for phosphatidylserine exposure on the plasma mem-
brane (Susin et al., 1999). Moreover, in the nucleus, AIF can
participate in chromatin condensation and caspase-indepen-
dent large-scale DNA fragmentation (Susin et al., 1999), likely
through direct electrostatic interaction with the DNA (Mate´
et al., 2002; Ye et al., 2002), as well as with other proteins that
possess latent DNase activities (Parrish and Xue, 2003). AIF-
deficient cells are resistant against a restricted panel of cell
death inducers. In particular, mouse embryonic stem cells
(ESCs) lacking AIF due to homologous recombination (Aif/y)
fail to undergo cavitation (Feraud et al., 2007; Joza et al., 2001;
Qi et al., 2012), which involves the first wave of programmed
cell death during ontogeny.
Beyond its role in apoptosis, AIF participates in normal mito-
chondrial metabolism. In all species investigated, the absence
of AIF causes a respiratory chain defect that is coupled to the
post-transcriptional downregulation of protein subunits
belonging to respiratory chain complexes I, III, and IV (Brown
et al., 2006; Be´nit et al., 2008; Hangen et al., 2010a; Pospisilik
et al., 2007; Vahsen et al., 2004). Mice affected by a hypomor-
phic AIF mutation (Harlequin mice) or bearing tissue-specific
knockout of AIF similarly develop severe neuromuscular mito-
chondriopathies leading to premature death (Klein et al., 2002;
Hangen et al., 2010a). In humans, mutations in AIF manifest as
familial X-linked diseases that have either of two different
phenotypes. First, AIF mutations can cause a severe pediatric
mitochondriopathy linked to reduced expression and function
of respiratory chain complexes (Berger et al., 2011; Ghezzi
et al., 2010). Second, the so-called Cowchock syndrome is
caused by a mutation of AIF that increases its cytocidal potential
(Rinaldi et al., 2012).
The relationship among AIF, respiratory function, and cavita-
tion is elusive. Here we report the discovery of an AIF-interacting1002 Molecular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Inprotein, CHCHD4, which provides a mechanistic link among
AIF deficiency, mitochondrial dysfunction, and failed cavitation
in ESCs.
RESULTS
AIF Interacts with CHCHD4
Immunoprecipitation of AIF from human cervical cancer cells
followed by mass spectrometric sequencing of peptides led to
the identification of CHCHD4.1, the human equivalent of yeast
Mia40 (Tim40) (Chacinska et al., 2004; Naoe´ et al., 2004) as an
AIF-binding partner (Figures 1A, 1B, and S1A). Human CHCHD4
is a soluble 16-kDa protein that localizes to the mitochondrial
IMS (Hofmann et al., 2005), where it participates in mitochondrial
import and catalyzes oxidative protein folding in cooperation
with the sulfhydryl oxidase GFER/ALR/Erv1p (Banci et al.,
2009; Chacinska et al., 2008; Fischer et al., 2013; Koch and
Schmid, 2014). Endogenous AIF and CHCHD4, which both co-
localized in mitochondria (Figure S1B), formed a stable complex
that persisted even after the treatment of the cells with the
translation inhibitor cycloheximide (CHX) (Figure S1C), and co-
immunoprecipitated in conditions in which neither respiratory
chain subunits nor GFER were detectable in the complex
(Figure 1B; data not shown). Protein pull-down experiments
revealed direct interaction of recombinant AIF with CHCHD4.
This direct protein-protein interaction was not affected by point
mutations of cysteine residues in CHCHD4 (Figure 1C) that pre-
viously have been implicated in its mitochondrial activity (Banci
et al., 2009; Fraga et al., 2014; Hofmann et al., 2005; Koch and
Schmid, 2014).
A subsequent scan of deletion mutants excluded the partici-
pation of the redox-active CX9C-CX9C domain of CHCHD4
in the interaction with AIF (Figures 1D and 1E). Rather, the
N-terminal 27 amino acids of CHCHD4 (p1-27N-CHCHD4)
were sufficient to interact with AIF (Figures 1D and 1E), and ac.
27-amino-acid synthetic peptide corresponding to this N termi-
nus competitively disrupted the interaction of recombinant
CHCHD4 with AIF (Figure S1D). While the interaction site of
CHCHD4 could be precisely mapped to its N terminus, the inter-
action site of AIF appeared to be conformational. Accordingly,
deletion of different domains of AIF resulted in the generation
of a protein that failed to interact with CHCHD4, and only full-
length AIF bound to CHCHD4 in cells (Figures S1E and S1F) as
well as in GST pull-down experiments (Figure S1G). A patho-
genic AIF mutation (E493V) that enhances its apoptotic activity
(but does not affect its respiratory activity) (Rinaldi et al., 2012)
did not alter the interaction with CHCHD4. In contrast, a mutant
AIF, which carries a point mutation (G308E) in the binding
domain to nicotinamide adenosine dinucleotide (NAD) and
causes a severe complex I+IV deficiency (Berger et al., 2011;
Ye et al., 2002), exhibited reduced CHCHD4 binding (Figures
S1E and 2E). The addition of reduced pyrimidine nucleotides
(NADH or NADPH), but not that of their oxidized equivalents
(NAD+ or NADP+), favored the interaction between AIF and full-
length CHCHD4 (Figures 2A and S2A–S2G), as well as that of
AIF and the N-terminal fragment of CHCHD4, p1-27N-CHCHD4
(Figure 2B).
Isothermal titration calorimetry (ITC) confirmed the binding of
p1-27N-CHCHD4 to AIF in a 1:1 stoichiometry in the presence
of NADH (Figure 2C). NADH failed to affect the structure of
p1-27N-CHCHD4 in conditions in which it altered that of AIF
(Churbanova and Sevrioukova, 2008), as determined by far-UV
circular dichroism (CD) (Figure 2D). NADHdid affect the structure
of the complex formed by p1-27N-CHCHD4 and AIF, as indi-
cated by subtraction of the CD profiles obtained for the mixture
of p1-27N-CHCHD4 plus AIF and the one obtained for AIF, in the
absence or presence of NADH (Figure 2D). These results support
the notion that the AIF-NADH complex possesses an increased
capacity to bind CHCHD4 in comparison with AIF alone and that
NADH levels stabilize the interaction between AIF and CHCHD4.
Yet another argument in favor of this interpretation could be ob-
tained with the aforementioned pathogenic AIF mutant (G308E),
which affects the NADH-binding domain of AIF (Figures S1E and
2E). In GST pull-down assays involving non-mutated AIF protein
immobilized to glutathione-sepharose beads and soluble
CHCHD4 protein, the addition of NADH favored the interaction
between both recombinant proteins (Figures 2A and 2F). How-
ever, the interaction between mutated G308E AIF protein and
CHCHD4 was reduced at the basal level and was scarcely
enhanced by the addition of NADH (Figure 2F).
Altogether, these results reveal the existence of the mitochon-
drial interactor of AIF, CHCHD4, which directly binds to the
NADH-AIF complex via its N-terminal domain.
CHCHD4 Is Required for Respiratory Chain Biogenesis
HumanCHCHD4 and its yeast orthologMIA40 are involved in the
import and assembly of mitochondrial IMS proteins (Banci et al.,
2009; Chacinska et al., 2004, 2008; Naoe´ et al., 2004), which then
impinge on the assembly and function of the respiratory chain
(Allen et al., 2005; Bihlmaier et al., 2007; Chacinska et al.,
2004; Dabir et al., 2007). To address the possibility that CHCHD4
might affect respiratory chain complexes in mammals, we
created mice in which Chchd4 was inactivated by mutationalMoleinsertion to express a b-galactosidase-neo (b-GEO) reporter
protein under the control of the Chchd4 promoter (Figure 3A).
Heterozygous expression of b-GEO was compatible with normal
embryogenesis, revealing ubiquitous expression of the b-GEO
transgene throughout development (Figure 3B). Intercrosses of
heterozygous mice for homozygous disruption of the Chchd4
locus yielded no Chchd4/ pups at birth. No Chchd4/
embryos were ever detected after embryonic day (E) E8.5 (Fig-
ure 3C). Chchd4/ embryos were always staged at E5.5–6
(retarded embryos in Figure 3C), indicating that Chchd4 deletion
causes a developmental arrest coupled with embryonic lethality
at the onset of gastrulation. The developmental retardation of
Chchd4/ embryos was accompanied by a major defect in
the expression of respiratory chain complex I subunit CI-20
(Figure 3D).
In accord with this observation, we found that knockdown of
CHCHD4 using two distinct small interfering RNAs (siRNAs) led
to a similar respiratory chain defect in human osteosarcoma
U2OS cells (Figure 4A). Thus, CHCHD4 depletion resulted in
reduced protein expression of several respiratory chain sub-
units, such as CI-20 and CIV-II, paralleling functional defects in
complexes I and IV, but not in complex V (Figures 4A–4E). As a
control, depletion of Mic19, a homolog and potential interactor
of CHCHD4 (Darshi et al., 2012; Pfanner et al., 2014), which
does not co-immunoprecipitate with the AIF/CHCHD4 complex
(Figure S3A), failed to mediate similar effects on the stability of
the analyzed respiratory chain subunits (Figure S3B).
Taken together, these findings indicate that CHCHD4 plays a
central role in the biogenesis of specific respiratory chain
complexes.
AIF Is Required for CHCHD4 Protein Expression
The knockdown of CHCHD4 did not diminish the abundance of
AIF (Figure 4A). In contrast, depletion of AIF led to a reduction
of CHCHD4 protein expression (Figures 4A and 4F), yet failed
to alter the levels of the related Mic19 protein (Figure S3B). The
reduction of CHCHD4 protein in AIF-depleted cells was not
accompanied by any change in the levels of CHCHD4 mRNA
(Figure 4G). The biochemical and functional consequences of
AIF depletion phenocopied that of CHCHD4 depletion, causing
selective defects of respiratory chain complexes I and IV (Figures
4A–4E). Moreover, the knockdown of AIF or CHCHD4 had similar
effects on the abundance of CHCHD4 substrates (Figures S3C–
S3E) NDUFA8 (Szklarczyk et al., 2011), COX17, and DDP1
(Hofmann et al., 2005), which were not detectable in the AIF/
CHCHD4 immunoprecipitate (Figure S3F), presumably because
the interaction between CHCHD4 and its substrates is rather
transient (Koch and Schmid, 2014; Sideris et al., 2009). Neither
AIF nor CHCHD4 affected the abundance of other mitochondrial
proteins such as VDAC, PINK, and HSP60 (Figures S3C
and S3D). The mitochondrial IMS-operating metalloprotease
YME1L (Baker et al., 2012; Jensen and Jasper, 2014) is (one
of) the protease(s) that participates in the degradation of
CHCHD4 substrates after depletion of AIF. Indeed, if the
siRNA-mediated knockdown of AIF was accompanied by the
simultaneous siRNA-mediated knockdown of YME1L, the deple-
tion of CHCHD4 substrates such as COX17 (the copper chap-
erone for complex CIV) and NDUFA8 (Szklarczyk et al., 2011)cular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Inc. 1003
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Figure 2. Impact of NADH on the Stabilization of AIF/CHCHD4 Complex
(A) Interaction of GST-tagged AIF with recombinant CHCHD4 (rCHCHD4) in the presence of pyrimidine nucleotides. GST-tagged AIF (103-613) was immobilized
on beads, pre-incubated (+) or not () with pyrimidine nucleotides (NAD, NADP, NADH, and NADPH), and then evaluated for its capacity to bind rCHCHD4.
Experiments were performed at least three times, yielding similar results.
(B) Interaction of GST-tagged mutants of CHCHD4 with AIF/NADH. The indicated WT or mutant GST-tagged CHCHD4 proteins (schematic presentation at right)
were immobilized on beads and evaluated for their capacity to bind recombinant AIF (103-613) pre-complexed (+) or not () with NADH. All experiments were
performed at least three times, yielding similar results.
(legend continued on next page)
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(an IMS-localized subunit of complex CI required for the stabili-
zation of the complex) was attenuated (Figure S3E).
AIF depletion by several non-overlapping siRNAs failed to
affect the mitochondrial transmembrane potential (Joza et al.,
2001; Figure S4C), yet caused a reduction of CHCHD4 protein
expression with a delay of several days (Figures 5A, 5B, and
S4D). Re-introduction of AIF expression by means of non-
interferable plasmid constructs suppressed the effects of an
AIF-specific siRNA on CHCHD4 expression (Figures S4A and
S4B). These experiments revealed that both long isoforms of
AIF, AIF1 and AIF2 (Hangen et al., 2010b), indistinguishably
supported the expression of CHCHD4. Mice carrying the hypo-
morphic Aifhq/y mutation (i.e., male mice from the Harlequin
strain), which develop signs of neurodegeneration at the adult
stage, manifested a progressive CHCHD4 defect in the brain
postpartum. This CHCHD4 defect preceded that of complex
I subunits during early adulthood, as detected by quantitative
immunoblots (Figures 5C, 5D, and S4E). The Aifhq/y-associated
defect in CHCHD4 protein expression occurred solely at the
post-transcriptional level and was observed also in other organs
from Aifhq/y mice (Figures S4F–S4H). AIF-deficient (Aif/y) ESCs
also manifested reduced CHCHD4 expression compared to
wild-type (WT) controls (Figures 5E and 5F).
Altogether, these findings suggest that AIF acts upstream of
CHCHD4 to ensure optimal mitochondrial function at the level
of selected protein complexes and that, in the absence of AIF,
CHCHD4 substrates are unstable and destroyed by proteases
such as YME1L.
AIF Controls the Mitochondrial Import of CHCHD4
As shown, AIF is required for the expression of CHCHD4 protein.
AIF depletion had no effect on the half-life of CHCHD4 after
translation blockade with CHX, excluding that the absence of
AIF enhances the degradation of CHCHD4 (Figure S5A). There-
fore, we investigated the potential effect of AIF on CHCHD4
import by creating an assay system. U2OS cells were trans-
fected with a plasmid coding for the Escherichia coli biotin ligase
BirA (de Boer et al., 2003) targeted to the mitochondrial IMS by
means of a mitochondrial localization sequence (MLS) derived
from the first 120 N-terminal residues of AIF (Otera et al.,
2005). This plasmid was dubbed MLS-BirA. Simultaneously,(C) ITC profiles of AIF interaction with the synthetic peptide p1-27N-CHCHD4 in th
CHCHD4 solution into PBS (supplemented with NADH) used as blank and hAIF(D
the heat evolved (kilocalories) per mole of p1-27N-CHCHD4 added to the buffe
Titration of hAIF(D1-103) with p1-27N-CHCHD4, corrected for the heat of p1-27N
is shown. The data were fitted to a single-site binding model. Plots are represen
(D) Secondary structure analysis of p1-27N-CHCHD4/hAIF(D1-103) interaction us
of NADH is shown. (Top left) CD spectra were collected on the buffer alone. (Botto
the flavonoid does not induce any structural change on the peptide. (Top middl
presence of NADH largely influences the structure of the protein. (Bottom m
hAIF(D1-103) solution. (Right) The same spectra shown at bottom middle after su
The peptide undergoes a large conformational rearrangement due to the interactio
cofactor. Spectra are representative of at least three independent determination
(E) Schematic localization of G308E mutation in the NADH-binding domain of AI
(F) Pull-down of GST-taggedWT AIF or mutated AIFG308E with the His-tagged CH
WT or mutated G308E were immobilized on beads, pre-incubated (+) or not (
immunoblot (top) was realized using the indicated antibody. The membrane w
Experiments were performed at least three times, yielding similar results.
See also Figure S2.
Molecells were co-transfected with a CHCHD4 fusion construct
(CHCHD4-b) that carried in its C terminus a biotin-accepting
peptide for site-specific biotinylation by BirA (Figure 6A). MLS-
BirA was exclusively detected in mitochondria (Figure 6C) facing
the IMS (data not shown) and effectively biotinylated CHCHD4-b
in a translation-dependent (CHX-repressible)manner (Figure 6B).
Knockdown of AIF reduced the biotinylation of CHCHD4-b as it
reduced the overall abundance of CHCHD4-b (Figure 6D). Thus,
knockdown of AIF negatively affected the expression of endog-
enous CHCHD4, the overall protein levels of CHCHD4-b, as well
as those of biotinylated CHCHD4-b, to a similar level (Fig-
ure S5B), in line with the interpretation that the translation-
dependent biotinylation of CHCHD4-b by MLS-BirA reflects its
overall abundance. Kinetic experiments, during which biotin
was removed from culture media before CHX treatment and
the translation was restarted by CHX removal in the presence
of biotin, confirmed that AIF depletion (by means of two distinct
siRNAs) reduced the rate of CHCHD4-b biotinylation (Figures 6E
and S5C).
Next, we explored the putative implication of AIF in translation-
coupled import by measuring co-translation within a fusion
construct composed by N-terminal CHCHD4 and C-terminal
unstable GFP (Li et al., 1998), which were separated by the 2A
self-cleaving peptide (de Felipe et al., 2006; Figure 6F). The 2A
self-cleaving peptide provokes ribosomal skipping, causing an
apparent cleavage at this site without the need of proteolysis
(de Felipe et al., 2006). We transfected this new construct into
cells and observed that the co-translation of both recombinant
CHCHD4 (upstream of 2A) and GFP (downstream of 2A) was
attenuated when AIF was depleted. This effect was quantified
in two ways, namely by assessing the GFP-dependent fluores-
cence of cells (by flow cytometry) and by measuring the expres-
sion of GFP by immunoblot, yielding concordant results (Figures
6F–6I). Hence, by interfering with the co-translational import of
CHCHD4 into mitochondria, AIF depletion also reduced the
translation of GFP in this system. In contrast, AIF depletion failed
to affect the translation of another, co-transfected control
plasmid (MLS-BirA) that also codes for a mitochondrial protein,
underscoring the specificity of the effects. Altogether, this assay
corroborates the hypothesis that AIF controls the translation-
coupled mitochondrial import of CHCHD4.e presence of NADH. (Top left) Raw data for sequential injections of a p1-27N-
1-103) solution (supplemented with NADH) are shown. (Bottom left) Plot shows
r solution (open circle) and into the hAIF(D1-103) solution (filled circle). (Right)
-CHCHD4 dilution, against the molar ratio of p1-27N-CHCHD4 to hAIF(D1-103)
tative of at least three independent determinations.
ing far-UV CD in the absence (filled circle, Co.) or presence (open circle, NADH)
m left) CD spectra were collected on the p1-27N-CHCHD4 solution. Addition of
e) CD spectra were collected on the hAIF(D1-103) solution. As expected, the
iddle) CD spectra were recorded on the combined p1-27N-CHCHD4 and
btraction of the hAIF(D1-103) contribution presented at top middle are shown.
n with the protein, but the conformational change is larger in the presence of the
s.
F is shown.
CHD4 protein, in the presence or absence of NADH. GST-tagged AIF (103-613)
) with NADH, and then evaluated for their capacity to bind rCHCHD4. The
as stained with a blue protein stain for GST-AIF loading control (bottom).
cular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Inc. 1005
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Figure 3. Impact of CHCHD4 Knockout on Respiratory Chain Complexes during Embryogenesis
(A) Schematic representation of the gene trap strategy used for the insertional mutagenesis ofCHCHD4 gene. The insertion of the bGEO cassette, at the vicinity of
exon 2, disrupts the endogenous coding sequence and allows the expression of a b-galactosidase-neo reporter mRNA that is initiated in the first exon ofCHCHD4
and reports the transcriptional activity of the locus.
(B) X-Gal staining of mutant embryos from E5.5 to E9 revealed a widespread expression of CHCHD4, with the exception of the visceral endoderm at the earliest
stages. EPC, ectoplacental cone; YS, yolk sac. Scale bars, 200 mM.
(legend continued on next page)
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Figure 4. Impact of AIF and CHCHD4 Deple-
tion on the Levels of Mitochondrial Proteins
(A) U2OS cell extracts (triplicates), subjected to the
transfection with siRNAs that deplete AIF (AIFa),
CHCHD4 (CHCHD4a, CHCHD4b), or Emerin as a
control (Co.1), were analyzed by immunoblot for
the abundance of the indicated proteins (A).
(B, C, and F) The relative expression levels of
proteins (with respect to complex V subunit CV-a)
were quantified by image analysis (B, C, and F). In
(F), the ratio of AIF or CHCHD4 protein to CV-a is
set to 100% in control siRNA-transfected cells.
(D and E) The relative deficiency of complex I and
IV activity (with respect to complex V) was
analyzed by spectrophotometric measurement of
individual respiratory chain complexes activities.
(G) Relative AIF or CHCHD4 mRNA levels were
determined by qRT-PCR, defining the ratio of AIF
or CHCHD4 to three housekeeping mRNAs in
control siRNA-transfected cells set to 100%.
Values are means ± SEM of triplicates. *p < 0.05,
**p < 0.01, ***p < 0.001 calculated by ordinary
one-way ANOVA followed by Bonferroni’s post-
analyses.
See also Figure S3.Enforced Mitochondrial CHCHD4 Import Restores
Respiration in AIF-Deficient Cells
The absence of AIF was incompatible with enforced high expres-
sion of HA-tagged CHCHD4 protein (Figure S6A). For this
reason, we attempted to restore the expression of CHCHD4 in
AIF-depleted cells by modifying its mitochondrial import
pathway and enforcing its attachment to the inner membrane,
with a MLS derived from the first 120 N-terminal residues of
AIF (Otera et al., 2005) fused to its N terminus (Figure 7A). The
expression level of this MLS-CHCHD4 chimera (MC) was not(C) CHCHD4 invalidation leads to embryonic lethality at gastrulation. Embryos indicated as retarded embryos
(CHCHD4/) embryos that were nearly always staged at E5.5–6, some heterozygous embryos (CHCHD4+
litters containing homozygous knockout embryos (bottom table). Scale bar, 200 mM.
(D) Impact of CHCHD4 mutation on the expression of respiratory chain complexes protein subunits. Extra
analyzed by immunoblot (left). The abundance of indicated proteins in the mutant embryo (/, deficient for th
analysis and normalized compared to the levels of same proteins in the embryo proficient for the expression o
control. Nd, not detectable.
Molecular Cell 58, 1001–101affected by one of the AIF-specific
siRNAs (AIFc), yet was strongly reduced
by another siRNA (AIFa) that targets the
stretch of the mRNA sequence corre-
sponding to the MLS shared by AIF and
MC (Figures 7B and S6B). Importantly,
MC was able to revert the defects in
DDP1 and respiratory chain complex
subunits (CI-20 and GRIM 19 from com-
plex I, CIV-II from complex IV, and the
CIV-chaperone COX17) secondary to
AIF depletion (Figures 7B and S6B). In
contrast, a control construct (MB,
composed of the same MLS from AIF
and an irrelevant protein, BirA) was
unable to reverse the respiratory chainsubunit defect induced by AIF depletion (Figure 7B). Mutation
of all functional cysteines contained in CHCHD4 abrogated the
capacity of the MC construct to restore the mitochondrial
defects of AIF-deficient cells (Figure S6C), underscoring the rele-
vance of the cysteine-dependent oxidoreductase activity of
CHCHD4.
Stable transfection with MC, but not with MB, could also
restore the expression of CI-20 in undifferentiated Aif/y ESCs,
as well as in Aif/y embryoid bodies (EBs) that are formed
from ESCs upon depletion of leukemia-inhibitor factor (LIF), awere staged at E5.5–6. In addition to homozygous
/) staged at E5.5–6 also were recovered from the
cts of individual embryos, staged at E5.5–6, were
e expression of CHCHD4) was quantified by image
f CHCHD4 (+/+) (right). Actin was used as a loading
4, June 18, 2015 ª2015 Elsevier Inc. 1007
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Figure 5. Kinetic Ordering of the AIF/
CHCHD4 Pathway
(A and B) Extracts of U2OS cells, transfected with
the indicated siRNAs for 1 to 4 days, were
analyzed by immunoblot (A), and the relative
abundance of AIF and CHCHD4 was quantified
by image analysis followed by normalization
compared to actin levels (B). Results were ex-
pressed as a percentage of control value (siRNA
Co.4) defined as 100%. Values are means ± SD of
duplicates. *p < 0.05, **p < 0.01, ***p < 0.001
calculated by ANOVA followed by Bonferroni’s
post-analyses.
(C and D) The kinetic impact of the HQmutation on
AIF, CHCHD4, and complex-I-20 protein expres-
sion was determined in brain samples collected at
the indicated day postpartum. Triplicate samples
from WT (Aif+/y) and mutant (Aifhq/y) mice were
analyzed by immunoblot (C), and the relative
abundance of each protein was determined by
quantitative image analysis followed by normali-
zation compared to actin levels. Results were
expressed as a percentage of control value,
with P60-WT defined as 100% (D). Values are
means ± SEM of triplicates. *p < 0.05, **p < 0.01,
***p < 0.001 calculated by ANOVA followed by
Bonferroni’s post-analyses.
(E and F) Mouse ESC lines AIF WT (Aif+/Y, two
independent cell lines) and AIF deficient (Aif/Y,
two independent cell lines) were analyzed by
immunoblot for the abundance of the indicated
proteins (E), and the relative expression levels of
proteins were quantified by image analysis and
normalized compared to the level of GAPDH (F).
See also Figure S4.cytokine that usually maintains the pluripotency and represses
the differentiation of ESCs (Murray and Edgar, 2001). This effect
was obtained both in normoxic (Figures 7C and 7D) and hypoxic
(Figures S6D and S6E) conditions. Concomitantly, MC, but
not MB, improved the function of respiratory chain complexes
I and IV in Aif/y ESCs (Figure 7E) and restored the capacity of
the cells to form cavitating EBs upon LIF removal. MC-express-
ing Aif/y EBs underwent cavitation in conditions in which MB-
expressing or untransfected (not shown) Aif/y EBs failed to
undergo cavitation (Figures 7F and 7G). In contrast, MC had no
impact on the formation and size of EBs (Figure 7G).
Altogether, these results indicate that restoring CHCHD4
levels can reverse the phenotype of Aif/y ESCs with respect to
their metabolic and cell death phenotypes.1008 Molecular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Inc.DISCUSSION
As shown here, there are several lines of
evidence that place CHCHD4 in the
pathway linking AIF deficiency to the defi-
cient biogenesis of respiratory chain
complexes. First, there is chronological
evidence. In Harlequin mice, which bear
a retroviral insertion in the first intron of
AIF, causing a reduction of its expression,
the defect in CHCHD4 becomes evidentbefore amajor reduction of respiratory chain complex I is detect-
able at the postnatal stage. Second, there is functional evidence
in favor of a mechanistic hierarchy between AIF and CHCHD4.
Depletion or deletion of AIF causes a reduction in the abundance
of CHCHD4. Conversely, knockdown of CHCHD4 fails to affect
the expression of AIF. Hence, AIF is required for CHCHD4
expression, not vice versa. Third, the depletion of either AIF or
CHCHD4 causes similar defects in a specific set of mitochondrial
proteins, including components of the respiratory chain com-
plexes I and IV and DDP1. Fourth, when the import of CHCHD4
into the mitochondrial IMS is rendered independent from AIF,
namely by fusing the MLS of AIF with CHCHD4, the resulting
chimeric protein MC is able to overcome the respiratory chain
defect that is normally detectable in AIF-depleted cells. This
A B
C
D E
F G
H I
Figure 6. Regulation of CHCHD4 Translation/Import by AIF
(A) Schematic representations show the biotinable CHCHD4-b that carries in its C terminus an acceptor peptide (GLNDIFEAQ(K)IEWHE) flanking a lysine residue
that is specifically biotinylated by BirA andMLS-BirA, the mitochondrion-targeted BirA, which is addressed to the organelle by means of anMLS derived from the
first 120 N-terminal residues of AIF.
(legend continued on next page)
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experimental observation closes the cycle of argumentation.
CHCHD4 depletion is indispensable for the phenotypic manifes-
tation of an AIF-related defect in oxidative phosphorylation.
How does AIF affect the expression levels of CHCHD4? Hav-
ing excluded the possibility that AIF might influence the levels
of CHCHD4 mRNA, we evaluated the hypothesis that AIF
would affect the import of CHCHD4 into mitochondria. To
test this possibility, we determined the capacity of AIF to
regulate the import of CHCHD4 protein in human cells. For
this, we first created an experimental system in which a
bacterial biotinylase specifically targeted to the IMS was
combined with a biotinable CHCHD4 (CHCHD4-b), meaning
that the degree of CHCHD4-b in vivo biotinylation reflects
its localization to mitochondria. Kinetic experiments led to
the conclusion that the import of CHCHD4 into mitochondria
was translation-dependent (because it only occurred in the
absence of CHX) and that it was affected by the abundance
of AIF. In AIF-deficient cells, the biotinylation (and hence
import) of CHCHD4-b by the IMS-targeted biotinylase was
reduced. Second, we developed a protein co-translation assay
in which unstable (non-mitochondrial) GFP was placed down-
stream of CHCHD4-b on the same mRNA, in the same open
reading frame, finding that AIF deficiency reduced the
abundance of GFP in conditions in which it affected
CHCHD4-b expression. Translation-dependent import is not a
rarity (Weis et al., 2013). However, to the best of our knowl-
edge, this is the first report that AIF can affect such an import
reaction.
How might the presence of AIF in mitochondria facilitate the
translation-dependent import of CHCHD4? It appears plausible
that AIF affects the import of CHCHD4 through a specific effect.
Indeed, AIF was found to physically interact within cells with
CHCHD4, and our results show that the AIF/CHCHD4 interaction
is a direct one, not requiring additional proteins. No specific(B) Assessment of translation-coupled import of CHCHD4 in the mitochondrion.
incubated in the absence (DMSO) or presence of CHX for 16 hr (schematic protoc
1 hr, in the absence (3) or presence (4) of CHX. Finally, the biotinylation of CHCH
samples and compared to that of control samples incubated for 17 hr in the abs
(C) Mitochondrial localization of MLS-BirA. The subcellular localization of MLS-B
indicated proteins in the mitochondrial and cytosolic extracts.
(D) Impact of AIF knockdown on the translation-coupled import of CHCHD4 in th
were transfected with control siRNAs (Co.2 and Co.3) or an AIF-specific siRNA (AIF
prepared from cells incubated in the presence of CHX for 16 hr and then washed a
are presented. The biotinylation of CHCHD4-b and the abundance of the indica
samples and compared to that of triplicate samples from cells transfected with c
(E) Impact of AIF knockdown on the kinetics of the translation-coupled import of
CHCHD4-b and MLS-BirA were transfected with control siRNAs (Co.1) or an AI
CHX-treatment protocol presented in the figure. Then, 16 hr after CHX treatment, c
CHX-free medium supplemented with 8 mM biotin. Finally, extracts were analyze
(F–I) Impact of AIF knockdown on the translation-coupled expression of CHCHD
single fusion ORF composed by an N-terminal CHCHD4 and a C-terminal unsta
cleaving peptide (de Felipe et al., 2006). (G) During the translation phase, the s
imported into the mitochondrion and biotinylated by MLS-BirA, while the GFP pro
by indirect immunofluorescence in the presence of phycoerythrin-coupled strepta
b-2A-GFP and MLS-BirA plasmids were transfected with control siRNA (Co.3)
(CHCHD4a). Four days post-transfection, the abundance of GFP in AIF knockdo
parallel to the indicated proteins (I) and compared to that of samples preparedwith
directly the fusion RNA CHCHD4-b-2A-GFP. The graph (H) shows the percentag
Values are means ± SEM of five independent experiments. *p < 0.05, **p < 0.01,
See also Figure S5.
1010 Molecular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier Ininteraction domain within AIF could be identified by deletion
scanning, suggesting that this interaction relies on the entire
tertiary structure of the AIF protein. In line with this interpretation,
we found that NADH (or NADPH) enhanced the binding of AIF to
CHCHD4, knowing that only the holo-AIF protein (but none of the
deletion mutants studied here) possesses NADH or NADPH
reductase activity (Mate´ et al., 2002; Ye et al., 2002). Moreover,
a mitochondriopathy-associated point mutation occurring within
the NADH-binding domain of AIF (Berger et al., 2011) reduced
the interaction with CHCHD4, and the addition of NADH barely
ameliorated the formation of the complex. In contrast to AIF,
the binding of CHCHD4 involved a short domain. The N-terminal,
27-amino-acid-long fragment of CHCHD4 was necessary and
sufficient for it to interact with AIF, while the redox function of
CHCHD4 was irrelevant to the CHCHD4/AIF interaction. The
N terminus of CHCHD4 is unstructured when examined by nu-
clear magnetic resonance (NMR) spectroscopy (Banci et al.,
2009). However, far-UV CD data and ITC profiles were compat-
ible with the idea that this peptide firmly interacts with AIF, in
particular in the presence of NADH. Future co-crystallization of
these interactors may confirm the hypothesis that the N terminus
of CHCHD4 acquires a defined structure as it binds to AIF. Irre-
spective of these incognita, it appears plausible that AIF may
drag the CHCHD4 N terminus into the mitochondrial IMS,
thereby facilitating its import. Once the entire CHCHD4 protein
has been taken up into this compartment, it may adopt itsmature
conformation and catalyze oxidative protein folding by virtue of
its capacity to form mixed disulfides with protein substrates
(Milenkovic et al., 2009; Sideris et al., 2009), thereby contributing
to optimal mitochondrial biogenesis (Yang et al., 2012). It is
possible, but still remains to be determined, that CHCHD4 bound
to AIF maintains its catalytic activity by transiently interacting
with its partner enzyme (Erv1) and its substrates. Obviously, it
will be interesting to investigate the possibility that CHCHD4U2OS cells, stably overexpressing CHCHD4-b and MLS-BirA proteins, were
ol in the figure). Then, cells (3) and (4) were washed and re-incubated, only for
D4-b and the abundance of the indicated proteins were analyzed on triplicate
ence (1, DMSO) or presence (2, CHX) of CHX.
irA was compared to that of an HA-tagged BirA by immunoblot analysis of the
e mitochondrion. U2OS cells stably overexpressing CHCHD4-b and MLS-BirA
b) and submitted to the CHX treatment protocol described in (B). Only extracts
nd re-incubated for 1 hr in the absence of CHX (16 hr CHX + 1 hr fresh medium)
ted proteins in the lysates of AIF knockdown cells are analyzed on triplicate
ontrol siRNA Co.2 and Co.3.
CHCHD4 into mitochondria. U2OS cells stably overexpressing the biotinable
F-specific siRNA (AIFc) and submitted to a successive biotin-deprivation and
ells were washed and incubated for the indicated times in the presence of fresh
d for the biotinylation of CHCHD4 and levels of the indicated proteins.
4-b and GFP. (F) The construct CHCHD4-b-2A-GFP is designed to produce a
ble GFP protein (Li et al., 1998), which are linked to each other by a 2A self-
elf-processing of the 2A peptide allows the production of CHCHD4-b that is
tein is diffused everywhere in the cell. Biotinylated CHCHD4-b (Bio) is revealed
vidin. Scale bar, 10 mm. (H–I) U2OS cells stably co-transfected with CHCHD4-
, AIF-specific siRNAs (AIFa, AIFb, or AIFc), or with CHCHD4-specific siRNA
wn cells is analyzed by fluorescence (flow cytometry) (H) or by immunoblot, in
cells transfectedwith control Co.3 siRNA or CHCHD4 siRNA that knocks down
e of GFP-positive cells observed after transfection with the indicated siRNA.
***p < 0.001 calculated by ANOVA followed by Bonferroni’s post-analyses.
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Figure 7. Phenotypic Reversal of the AIF Defect by Mitochondrion-Targeted CHCHD4
(A) Schematic representation shows the mitochondrion-targeted CHCHD4 (MC) and BirA (MB), which both share an identical MLS derived from the first 120
N-terminal residues of AIF.
(B) Impact of MC and MB on the abundance of mitochondrial proteins of AIF-depleted cells. U2OS cells were stably transfected with either MC or MB, and then
subjected to the knockdown of Emerin (control, Co.1) or AIF, using either an siRNA that only targets AIF (AIFc) or another siRNA (AIFa) that targets both AIF and
MC or MB (which all contain identical, AIF-derived N-termini). The abundance of the indicated proteins was determined by immunoblot.
(C and D) Impact of MC andMB on the abundance of mitochondrial proteins in AIF-null mutant cells. Mutant (Aif/y) murine cells were stably transfected with MC
or MB and grown in the conditions of high oxygen tension (normoxia). Then, lysates were prepared from ESCs (grown in the presence of LIF) or EBs (EB4 and
EB10 generated, respectively, by the withdrawal of LIF for 4 and 10 days) and analyzed for the expression of the transgene and respiratory chain-related proteins
(C). The relative expression level of CI-20 subunit protein was quantified by image analysis and normalized compared to the level of CV-a protein subunit (D).
Values are means ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 calculated by one-way ANOVA followed by Bonferroni’s
post-analyses. Data are representative of at least three experiments that yielded comparable results.
(E) Histograms show the respiratory function of mutant (Aif/y) ESCs stably transfected with MC or MB. Values are means ± SEM of triplicates. *p < 0.05,
**p < 0.01, ***p < 0.001 calculated by t test (with Welch’s correction).
(F and G) Phenotype of EBs derived fromWT (Aif+/y) andmutant (Aif/y) ESCs stably transfected with MC or MB. Representative pictures are shown for EBs of the
indicated genotype (bar, 200 mm) (F). Histograms show the percentage of cystic EBs (G, top) and themeasure of their perimeter (G, bottom) is presented. See also
Figure S6.
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mutations could provoke similar phenotypes as those described
for its interactors, AIF and Erv1 (Di Fonzo et al., 2009).
Unexpectedly, we found that the phenotype of AIF-null (AIF/y)
ESCs with regard to cavitation (Feraud et al., 2007; Joza et al.,
2001) was secondary to the mitochondrial dysfunction.
Following up the finding that partial inhibition of the respiratory
chain complex I with rotenonewas sufficient to abolish cavitation
in WT EB (Feraud et al., 2007), we observed that transfection
of AIF/y ESCswith mitochondrion-targeted CHCHD4, amaneu-
ver that corrected the mitochondrial defect, also restored the
capacity ofAIF/y ESCs to undergo cavitation upon in vitro differ-
entiation. At present, the precisemolecular mechanisms that link
oxidative phosphorylation to cavitation-associated programmed
cell death remain elusive.
Altogether, we conclude that the effect of AIF on the biogen-
esis of the mitochondrial respiratory chain complexes is medi-
ated by its physical and functional interaction with CHCHD4,
an essential mitochondrial intermembrane protein.
EXPERIMENTAL PROCEDURES
Animals
All procedures and animal experimentation protocols (project authorization
2012-076) were reviewed and deemed acceptable by Registered Ethical Com-
mittee 26, and carried out in the animal facility of Gustave Roussy (official
agreement number E-94-076-11).
Cell Culture and Transfection
Human osteosarcoma U2OS cells (ATCC HTB-96) were cultured as described
previously (Hangen et al., 2010b). Pools of transfected U2OS cells were estab-
lished by co-transfection with plasmids described in the Supplemental Exper-
imental Procedures followed by selection in 0.5 mg/ml puromycin (Invivogen)
and 0.5 mg/ml geneticin (Life Technologies). Mouse ESC culture and manipu-
lation protocols are described in the Supplemental Experimental Procedures.
Translation-Coupled Mitochondrial Import of CHCHD4
U2OS cells stably overexpressing the biotinable CHCHD4 (CHCHD4-b) and
the mitochondrion-targeted BirA (MLS-BirA), transfected or not with siRNA,
were incubated in the presence of the reversible protein translation inhibitor
CHX for 16 hr. Then, for the purpose of reactivating protein translation, CHX
was washed away using PBS and cells were re-incubated, only for 1 hr, in a
fresh medium free of CHX. Finally, triplicate samples were extracted with
23SB (4% SDS, 20% glycerol, 125 mM Tris-HCl (pH 6.8), and 200 mM
DTT), boiled, resolved with SDS/PAGE (NUPAGE, Life Technologies), and
analyzed by immunoblot. The kinetic of in vivo biotinylation of CHCHD4-b
was assessed using the aforementioned protocol except that, 24 hr before
the addition of CHX, the regular medium was replaced by a biotin-depleted
one (prepared as described in the Supplemental Experimental Procedures).
After 16 hr of CHX treatment (in the absence of biotin), cells were washed
with PBS and incubated for 0 to 60 min with the biotin-depleted CHX-free
medium supplemented with 8 mM biotin (Sigma-Aldrich). To assess the in vivo
biotinylation of CHCHD4-b, after transferring the SDS-PAGE-separated
proteins, the nitrocellulose membrane (Bio-Rad) was first blocked by incuba-
tion with 1% BSA diluted in TBST buffer (10 mM Tris-HCl (pH 8.0), 150 mM
NaCl, and 0.05% Tween 20) for 1 hr and then incubated for a further 1 hr
with a horseradish peroxidase-conjugated streptavidin (Sigma-Aldrich). Finally
the biotin-streptavidin bindingwas detected with the enhanced chemilumines-
cence (ECL) detection kit (GE Healthcare).
Statistical Analyses
GraphPad Prism 5.0d software was used for statistical analyses. Groups were
compared by one-way ANOVA followed by Bonferroni post-analyses or un-
paired two-tailed t test with Welch’s corrections. The criterion for statistical
significance was set at p < 0.05. Data are expressed as mean ± SEM.1012 Molecular Cell 58, 1001–1014, June 18, 2015 ª2015 Elsevier InSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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